Tim van Groningen

945 total citations
7 papers, 214 citations indexed

About

Tim van Groningen is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Tim van Groningen has authored 7 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Oncology. Recurrent topics in Tim van Groningen's work include Neuroblastoma Research and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Melanoma and MAPK Pathways (2 papers). Tim van Groningen is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Melanoma and MAPK Pathways (2 papers). Tim van Groningen collaborates with scholars based in Netherlands, United Kingdom and Italy. Tim van Groningen's co-authors include Jan Köster, Remco van Doorn, Johan van Nes, Rogier Versteeg, Alvin Chan, Peter van Sluis, Roderick C. Slieker, C. Dilara Savci‐Heijink, Peter Stroeken and Richard Volckmann and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Tim van Groningen

5 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim van Groningen Netherlands	5	128	125	78	71	25	7	214
Niloufar Javanmardi Sweden	8	128 1.0×	167 1.3×	81 1.0×	62 0.9×	14 0.6×	10	209
Verena Körber Germany	4	105 0.8×	124 1.0×	92 1.2×	48 0.7×	18 0.7×	5	195
Nikhil Munshi United States	4	178 1.4×	69 0.6×	44 0.6×	72 1.0×	16 0.6×	11	226
Selina Jansky Germany	3	100 0.8×	104 0.8×	83 1.1×	39 0.5×	20 0.8×	3	178
Noémie Braekeveldt Sweden	5	96 0.8×	140 1.1×	100 1.3×	66 0.9×	8 0.3×	5	200
Richard Y. Ebright United States	4	157 1.2×	54 0.4×	118 1.5×	45 0.6×	18 0.7×	5	215
Adam Kosti United States	9	189 1.5×	46 0.4×	149 1.9×	29 0.4×	13 0.5×	15	255
Mellissa Hicks United States	5	90 0.7×	29 0.2×	52 0.7×	70 1.0×	11 0.4×	7	160
Laura Creevey Ireland	5	177 1.4×	75 0.6×	128 1.6×	31 0.4×	14 0.6×	6	221
Teng Fei Qi China	4	292 2.3×	57 0.5×	261 3.3×	49 0.7×	20 0.8×	8	377

Countries citing papers authored by Tim van Groningen

Since Specialization

Citations

This map shows the geographic impact of Tim van Groningen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim van Groningen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim van Groningen more than expected).

Fields of papers citing papers by Tim van Groningen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim van Groningen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim van Groningen. The network helps show where Tim van Groningen may publish in the future.

Co-authorship network of co-authors of Tim van Groningen

This figure shows the co-authorship network connecting the top 25 collaborators of Tim van Groningen. A scholar is included among the top collaborators of Tim van Groningen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim van Groningen. Tim van Groningen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sluijter, Marjolein, Tim van Groningen, Remco van Doorn, et al.. (2025). Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding. Communications Biology. 8(1). 1561–1561.

2.

Slieker, Roderick C., et al.. (2022). Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma. Journal of Investigative Dermatology. 143(1). 18–25.e1. 44 indexed citations

3.

Rashid, Mamunur, Clare Pacini, Alastair Droop, et al.. (2020). Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma. Pigment Cell & Melanoma Research. 34(1). 122–131. 14 indexed citations

4.

Groningen, Tim van, Nurdan Akogul, Ellen M. Westerhout, et al.. (2019). A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma. Nature Communications. 10(1). 1530–1530. 95 indexed citations

5.

Zogchel, Lieke M. J. van, Ilse Timmerman, Lily Zappeij‐Kannegieter, et al.. (2019). Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel. JCO Precision Oncology. 1–11. 28 indexed citations

6.

Versteeg, Rogier, Tim van Groningen, Linda J. Valentijn, et al.. (2016). Abstract 2453: Neuroblastoma is bi-phasic and includes classical neuro-epithelial cells and chemo-resistant mesenchymal cells. Cancer Research. 76(14_Supplement). 2453–2453.

7.

Nes, Johan van, Alvin Chan, Tim van Groningen, et al.. (2013). A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma. Clinical Cancer Research. 19(13). 3485–3494. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact